Inputs: momentum, trendVelocity
Mixed signal: momentum 58/100, trend 54/100.
Prediction result · Ensemble engineUpdated 8:00 PM
BIIBBIIB stock price outlook
$253.62+1.59% since prev closeBullish
BIIB is up 1.59% since the previous close on the latest cached quote at $253.62. Mixed signal: momentum 58/100, trend 54/100.
Universal leanStock
BIIB
BIIB
$253.62+1.59%
LEANSOFT mild bid
WHY
- BIIB is up 1.59% since the previous close on the latest cached quote at $253.62. Mixed signal: momentum 58/100, trend 54/100.
- Bull input: Oscillator at 56 — healthy uptrend region.
RISK
Quote is stale: last cached refresh was 2026-10-30T20:00:57.165Z.
INVALIDATE
Invalidate on a decisive break of the session bid, catalyst reversal, or model edge flipping bearish.
AI Signal
Bullish · Bullish setup
live data
STALE FEED WARNING. Cached quote refreshed 2026-10-30T20:00:57.165Z. Change is measured since the previous close.
Quote source
Cron batch chart feed 2026-10-30T20:00:57.165Z
Move since previous close
+1.59%
News Sentiment55/100
Price Momentum58/100
Trend Velocity54/100
Volatility Risk46/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on BIIB
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgeLeanNeutral
Inputs: newsSentiment, dayChange
Sentiment 55/100 + price 1.6% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 45/100 with price drift 1.6% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 46/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 55/100 vs week change 0.5% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.0% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 56 — healthy uptrend region.
Inputs: momentum, dayChange, vsSma50
Momentum 58/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 55/100 and weekly change 0.5% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 45/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 46/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 60% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 55/100 and momentum 58/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance 0.0% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 56 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 58/100, trend 54/100.
- Sentiment 55/100 + price 1.6% are both mid-range.
- Price within 0.0% of the 50d SMA — no clear structural read.
Counter-trees
- Oscillator at 56 — healthy uptrend region.
Bull Case
- Oscillator at 56 — healthy uptrend region.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance UK58
Biogen Inc. (BIIB) stock price, news, quote and history - Yahoo Finance UK
10/30/2026, 7:33:28 PM
CMC Markets56
BIIB Stock Earnings Preview: What’s Next for Biogen as its MS Business Wanes? - CMC Markets
10/27/2026, 3:32:29 PM
TradingView61
BIIB's Q3 Earnings Beat, New Drugs Aid Sales, '26 EPS View Tightened - TradingView
10/28/2026, 4:11:00 PM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Market cap
- $37.49B
- 52-week range
- $258.78/$138
- Volume
- 1,303,307
- Avg volume
- 1,077,708
- Analyst 1-yr target
- $260.00
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Not yet scheduled
Estimate
N/A
Actual
$2.62
- • Last report Oct 28, 2026 (Sep 2026): EPS $2.62 vs $2.06 expected, +27.18% surprise.
- • Beat estimates in 4 of the last 4 quarters.
Risk Warnings
- • Quote is stale: last cached refresh was 2026-10-30T20:00:57.165Z.
- • Quotes can be delayed. Research only, not investment advice.
BIIB questions
What is the MarketPicks AI signal for BIIB stock (BIIB)?
As of Oct 30, 4:00 PM ET, the ensemble reads bullish on BIIB — bullish — 1 of 16 bots up, with 1 bull, 0 bear and 15 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest BIIB price on MarketPicks?
BIIB was $253.62 on the latest quote (Oct 30, 4:00 PM ET), +1.59% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for BIIB mean?
Scores run from 0 to 100, with 50 neutral. BIIB shows momentum 58/100, trend velocity 54/100 and volatility risk 46/100, with news sentiment at 55/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.